Showing posts with label Alzheimer's disease. Show all posts
Showing posts with label Alzheimer's disease. Show all posts

Feb 26, 2016

Understanding Protein Structure and Function: How Shape Determines Role in the Body

Proteins are essential molecules that drive nearly every biological process in the body. What makes them so effective is their unique ability to recognize and attach to specific targets—much like a key fitting into a lock. This precise interaction depends heavily on the protein’s shape. Whether it's an antibody identifying a virus or morphine binding to a pain receptor, the shape compatibility is what makes the function possible.


The Four Levels of Protein Structure

Proteins are not just simple chains of molecules; their function depends on how they are structured at multiple levels. These structural levels define how a protein folds and behaves in the body.

1. Primary Structure

This is the basic sequence of amino acids linked together in a straight line, like beads on a string.

2. Secondary Structure

Here, the amino acid chain begins to coil or fold into common patterns such as alpha-helices or beta-sheets.

3. Tertiary Structure

This is the complete 3D shape of a single folded protein. It’s this form that allows proteins to carry out specific tasks.

4. Quaternary Structure (only in some proteins)

When multiple folded protein chains (also called subunits) come together, they form a larger, more complex structure.

Only when a protein folds correctly into its unique three-dimensional form can it perform its intended biological role.


The Discovery: Protein Folding and Function

In the mid-1950s, American biochemist Christian Anfinsen began pioneering research into how a protein’s shape is linked to its function. Working at the National Institutes of Health, he focused on an enzyme called ribonuclease, which breaks down RNA. This enzyme was ideal for research because it was small, stable, and well-studied.

In a groundbreaking experiment in 1957, Anfinsen disrupted the enzyme’s 3D structure, causing it to lose its activity. Remarkably, when the conditions were reversed, the protein spontaneously folded back into its original form—and regained full function.

This led to a critical insight: a protein’s ability to fold into its functional shape is determined entirely by its amino acid sequence.


The Thermodynamic Hypothesis

Anfinsen proposed what became known as the thermodynamic hypothesis. He suggested that proteins naturally fold into the most stable, low-energy configuration possible. In other words, the protein’s final shape isn't random—it’s driven by physics and encoded in the sequence of amino acids.

This discovery fundamentally changed how scientists understand protein biology. In recognition of his work, Anfinsen received the Nobel Prize in Chemistry in 1972.


When Folding Goes Wrong: Protein Misfolding and Disease

Not all proteins fold correctly—and when they don’t, the consequences can be serious. Misfolded proteins are believed to play a central role in several neurodegenerative diseases, including:

  • Alzheimer’s disease
  • Parkinson’s disease
  • Huntington’s disease

These conditions are often associated with the build-up of amyloid proteins, which are incorrectly folded versions that accumulate in the brain. While the exact causes are still being studied, both aging and genetic factors are thought to increase the risk of protein misfolding.


Final Thoughts

Protein structure is the foundation of protein function. From unlocking cellular processes to triggering disease when things go wrong, the way a protein folds determines everything. Thanks to pioneering research by scientists like Christian Anfinsen, we now understand that this complex folding is not just a biological curiosity—it’s the key to life itself.


Immunoglobulin M (IgM), the largest antibody present in the human circulatory system, is the first to respond during an infection. Its presence is frequently utilized as a key indicator in the diagnosis of infectious diseases.

Dec 14, 2014

Effects of Drugs on Coordination

Drugs that affect the nervous system have two primary effects: they impact the limbic system and either promote or decrease the action of a particular neurotransmitter. One such drug is nicotine, an alkaloid derived from tobacco. Nicotine causes neurons to release dopamine in the central nervous system (CNS), while stimulating post-synaptic receptors in the peripheral nervous system (PNS), leading to increased activity. Nicotine also increases heart rate and blood pressure, digestive tract mobility, and can even induce vomiting, as well as causing water retention in the kidney.

 

Common nervous disorders

There are several common nervous disorders, including Parkinson's disease, epilepsy, and Alzheimer's disease.

Parkinson's disease

Parkinson's disease is caused by the death of cells in the brain that produce dopamine, resulting in symptoms such as slowness of movement, tremors, and rigidity. While the disease usually appears between the ages of 50 and 60, it progresses slowly, and patients may live for many years. Head trauma can also cause Parkinson's disease. Effective drugs for treating Parkinson's disease include L-dopa, carbidopa, and glial-derived growth neurotrophic factor (GDNF), which boosts the uptake of dopamine.

Epilepsy

Epilepsy is one of the convulsive disorders of nerves, characterized by abrupt transient symptoms of motor, sensory, psychic, or autonomic nature, frequently associated with changes in consciousness. The disease is believed to be caused by sudden, transient alterations in brain function associated with excessive rapid electric discharges in gray matter. Emotional disturbances can play a significant role in triggering seizures. Anticonvulsant drugs are used to treat epilepsy, and patients should avoid alcohol as it can aggravate the condition. Electroencephalography is an essential test in the study of epilepsy.

Alzheimer's disease

Alzheimer's disease was first discovered by Alois Alzheimer in 1907. It is characterized by a gradual loss of reasoning that begins with memory lapses and ends with an inability to perform daily activities. Alzheimer's disease affects two key parts of the brain: the cortex of the cerebral hemisphere, which is the conscious part of the brain, and the hippocampus, which is involved with memory. The disease is difficult to diagnose because its symptoms are similar to those of other diseases that cause dementia. However, brain tissue under a microscope shows protein plaques accumulating outside brain cells and tangled deposits of protein appearing inside the cells. Both plaques and tangles are caused by the accumulation of abnormal proteins. There is evidence that high levels of aluminum may contribute to the onset of the disease, but it appears that a shortage of the neurotransmitter acetylcholine in the brain is a primary factor. Drugs that enhance acetylcholine production are available for the treatment of Alzheimer's disease.